Related Experiment Videos
Intermediate golgi alpha-D-mannosidosis and mucolipidosis II and III
Abstract:
We have examined extracts of fibroblasts from patients with mannosidosis, mucolipidosis (ML) II, ML III, and normal controls for alpha-D-mannosidase activity against 4-methylumbelliferyl-alpha-D-mannopyranoside to test for the presence of the "intermediate" pH 5.5 enzyme activity that has been called the "Golgi mannosidase." Fibroblast extracts were prepared by sonication and sedimented to separate membrane-associated activities from cytosolic and lysosomal alpha-D-mannosidases. Membranes were extracted by salt washes (0.4 M NaCl) to desorb the lysosomal enzymes that sedimented with membranes. The alpha-D-mannosidase activity remaining with membranes showed many properties described for the Golgi mannosidase including: 1) an "intermediate" pH optimum (pH optimum (pH 5.5-6.0), 2) activity with the synthetic 4-methylumbelliferyl substrate, 3) lack of inhibitability by 200 mM methyl- alpha-D-mannopyranoside, and 4) partial resistance to solubilization by salt washing, and to a single extraction with the non-ionic detergent Triton X-100. This intermediate activity was the major alpha-D-mannosidase activity remaining in membranes from normal fibroblasts following sedimentation and salt washing, and was the major component of the alpha-D-mannosidase activity in extracts of fibroblasts from patients with mannosidosis, ML II, and ML III, in all of which, the lysosomal "acid" alpha-D-mannosidase was greatly reduced. The specific activity of intermediate alpha-D-mannosidase in membranes from fibroblasts from patients with mannosidosis, ML II, and ML III was not reduced compared to that of fibroblasts from controls. These studies provided no evidence to support the prior suggestion of a deficiency of "Golgi mannosidase" in ML II or ML III.
Insights
This study investigated alpha-D-mannosidase activity in fibroblasts from patients with mannosidosis and mucolipidosis (ML) II/III. Results show no deficiency in the "Golgi mannosidase" in these conditions, challenging previous suggestions.
Area of Science:
- Biochemistry
- Cell Biology
- Enzymology
Background:
- Lysosomal alpha-D-mannosidase deficiency causes mannosidosis and mucolipidosis (ML) II/III.
- A distinct
- intermediate
- pH 5.5 alpha-D-mannosidase activity, termed
- Golgi mannosidase
- , has been proposed to be deficient in ML II/III.
Purpose of the Study:
- To investigate the presence and properties of the
- intermediate
- pH 5.5 alpha-D-mannosidase activity in fibroblasts from patients with mannosidosis, ML II, and ML III.
- To determine if this activity is deficient in these genetic disorders.
Main Methods:
- Fibroblast extracts were prepared using sonication and differential sedimentation.
- Membrane-associated alpha-D-mannosidase activities were isolated via salt washes and detergent extraction.
- Enzyme activity was assayed using 4-methylumbelliferyl-alpha-D-mannopyranoside at varying pH.
Main Results:
- The
- intermediate
- pH 5.5 alpha-D-mannosidase activity exhibited properties consistent with the proposed
- Golgi mannosidase
- , including substrate specificity and resistance to solubilization.
- This intermediate activity was the major alpha-D-mannosidase in membranes from normal fibroblasts after lysosomal enzyme removal.
- Specific activity of the intermediate alpha-D-mannosidase was not reduced in fibroblasts from patients with mannosidosis, ML II, or ML III compared to controls.
Conclusions:
- Fibroblasts from patients with mannosidosis, ML II, and ML III do not exhibit a deficiency in the
- intermediate
- pH 5.5 alpha-D-mannosidase.
- These findings do not support the hypothesis that
- Golgi mannosidase
- is deficient in ML II or ML III.